July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Match Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MTCH
December 08, 2024 06:34 ET | The Rosen Law Firm PA
NEW YORK, Dec. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Match Group, Inc. (NASDAQ: MTCH) between May 2, 2023 and...
China-ASEAN Marathon 2024 Dimulai di Kota Fangchenggang
December 08, 2024 04:48 ET | 2024 China-ASEAN Marathon
KOTA FANGCHENGGANG, Tiongkokso, Dec. 08, 2024 (GLOBE NEWSWIRE) -- Pada 24 November silam, China-ASEAN Marathon 2024 dimulai di Taman Budaya Samudra Teluk Beibu di Kota Fangchenggang. Lebih dari...
elitesignals-design-25.png
EliteSignals Unveils Revolutionary Forex Trading Bot: EliteX
December 08, 2024 02:32 ET | EliteSignals
TORONTO, Dec. 08, 2024 (GLOBE NEWSWIRE) -- EliteSignals, the premier platform for beginner and intermediate traders, is proud to announce the launch of EliteX, a cutting-edge forex trading bot...
logo.jpg
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
December 07, 2024 19:12 ET | Genmab A/S
Media ReleaseCOPENHAGEN, Denmark; December 7, 2024 Results show 96 percent overall response rate (ORR), 87 percent complete response (CR), and 80 percent 21-month progression-free survival (PFS) in...
Regeneron Logo.jpg
Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab
December 07, 2024 19:00 ET | Regeneron Pharmaceuticals, Inc.
Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease control, as measured by lactate...
ADPT new logo.jpg
Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions
December 07, 2024 18:30 ET | Adaptive Biotechnologies
New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies show depth of response at 10-6 provides more accurate assessment...
Caribbean Airlines B
Caribbean Airlines Brings the Region Closer with New Service to Guadeloupe
December 07, 2024 17:39 ET | Caribbean Airlines Limited
Piarco, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Caribbean Airlines announces the start of its new service to the French island of Guadeloupe, marking a significant milestone in the airline’s commitment to...
KTMC-Logo_RGB.jpg
Class Action Announcement for Celsius Holdings, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Celsius Holdings, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
December 07, 2024 17:38 ET | Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., Dec. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the...
KTMC-Logo_RGB.jpg
Class Action Announcement for Zeta Global Holdings Corp. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Zeta Global Holdings Corp. - Contact Kessler Topaz Meltzer & Check, LLP
December 07, 2024 17:01 ET | Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., Dec. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the...
Pennsylvania Skill,
Pennsylvania Skill, powered by Pace-O-Matic, Responds to Commonwealth Court Ruling in Favor of Skill Games
December 07, 2024 15:59 ET | Pace-O-Matic
Harrisburg, PA, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Pace-O-Matic is pleased, and not surprised, that the Commonwealth Court agrees the ban passed by the Philadelphia City Council is unlawful. Lifting...